Tradestie Institutional Equity Comparison Engine

VOR vs INVA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

INVA Overall Edge

INVA Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Innoviva, Inc. Common Stock (INVA) driven by superior Valuation, Growth & Margin, Options & Structure while VOR counters with relative strength in Momentum & Technical. Fundamentally, VOR trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus INVA at 8.6x Forward P/E and 39.5% operating margin (-1.6% YoY). In options structure, VOR sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro) against INVA sits in UNCLASSIFIED (4th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner INVA
VOR N/M vs INVA 8.6x Fwd P/E
Growth & Margin Winner INVA
Op Margin 0.0% vs 39.5% ยท YoY +0.0% vs -1.6%
Momentum & Technical Winner VOR
1Y +94.6% vs -16.7% ยท 52W Pos 64% vs 1%
Options & Structure Winner INVA
CONSOLIDATION (6th %ile IV) vs UNCLASSIFIED (4th %ile IV)
VOR NASDAQ
Vor Biopharma Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$18.97
-2.32% 1D
Market Cap $1.2B
1M Return +5.21%
1Y Return +94.56%
Forward P/E N/M
Unified AI Score
57.8 / 100 HOLD
Tech 50.0 Fund 55.0 Flow 66.0 Mom 50.0
INVA NASDAQ
Innoviva, Inc. Common Stock
Pharmaceutical Preparations
$18.49
-2.84% 1D
Market Cap $1.4B
1M Return -11.02%
1Y Return -16.71%
Forward P/E 8.6x
Unified AI Score
48.9 / 100 HOLD
Tech 39.0 Fund 59.0 Flow 66.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: VOR +94.56% INVA -16.71% Spread: +111.27 pp (VOR Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
VOR TTM Op. Margin: 0.0% INVA TTM Op. Margin: 39.5%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on VOR vs INVA. Trailing 12-month operating profitability (VOR 0.0% vs INVA 39.5%) and valuation multiples (VOR N/M vs INVA 8.6x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: VOR (4) vs INVA (6)
Institutional Metric VOR INVA Criterion Row Winner
Market Capitalization Scale $1.2B $1.4B Larger Scale INVA
Trailing P/E Ratio Valuation 0.1x 8.1x Lower Multiple VOR
Forward P/E Ratio Valuation N/M 8.6x Lower Multiple INVA
Revenue Growth (YoY) Growth +0.0% -1.6% Higher Growth VOR
Operating Margin (TTM) Profitability 0.0% 39.5% Higher Margin INVA
Net Profit Margin Profitability 0.0% 44.1% Higher Margin INVA
Return on Equity (ROE) Capital Efficiency -125.4% 18.0% Higher ROE INVA
52-Week Range Position Momentum 64% ($6โ€“$26) 1% ($18โ€“$25) Stronger Trend VOR
Beta / 30D Volatility Risk Regime 1.90ฮฒ ยท 61% Vol 0.32ฮฒ ยท 37% Vol Lower Realized Risk INVA
Unified Institutional Score Composite Signal 57.8 / 100 (HOLD) 48.9 / 100 (HOLD) Higher Composite VOR

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full VOR vs INVA Buy Guide
VOR CONSOLIDATION
52d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live VOR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
INVA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 4th %ile
IV Regime Compressed (<25th %ile)
Live INVA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither VOR nor INVA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.